Autism clues: UC Davis team spots two new potential biomarkers of the condition

A research team with the UC Davis MIND Institute believes an excess of cerebrospinal fluid and enlarged brain size in infancy could be two biomarkers for autism. They identified both through a study of 55 infants from 6 months old to three years of age, 33 of which had an older autistic sibling. They found that by ages 6 to 9 months, children who developed autism had more than the usual amount of cerebrospinal fluid around the brain. Additionally, autistic children showed signs of enlarged brains before 2 years of age, based on MRI scans. The study is detailed in the journal Brain, which is published by Oxford University Press. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.